News & Articles

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available

The new product line includes the MutaPLEX RT-PCR assay and ELISA kits to detect IgM and IgG antibodies

The IgA, IgG, and IgM assays are formatted for optimal functionality in diagnostic laboratories

The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa

Hear from AstraZeneca expert Dr. Michael Surace on the biological and technical considerations for multiplex panels in this on-demand webinar

The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions

Huber's high precision temperature control technology directed towards manufacturing test chemicals and PPE

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2

Join this upcoming webinar for a review of an antibody discovery campaign targeting a cell surface receptor implicated in cancer

Emergency use authorization granted for new biomaterial collection approach

The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers

SelectScience hears from Prof. Harald Kolmar, TU Darmstadt, on an exciting new approach in cancer therapy

To be in with a chance of winning a $500 Amazon voucher, simply cast your vote for the product that has made the most difference to your research

Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis

Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals

The test results are designed to enable differential diagnosis in under 2.5 hours

Recent funding from the BARDA award helped the company accelerate development and validation

In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development

New IgM and IgG antibody assays will help indicate whether a person has developed immunity against COVID-19

The scientific community is working at full speed to fight the severe acute respiratory syndrome

The rapid delivery program is designed to provide critical laboratory equipment in this time of need